Goldman Sachs Group Inc Direxion Daily S&P Biotech Bea Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Goldman Sachs Group Inc holds 37,933 shares of LABD stock, worth $209,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,933
Previous 35,596
6.57%
Holding current value
$209,390
Previous $259,000
7.34%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LABD
# of Institutions
27Shares Held
2.68MCall Options Held
973KPut Options Held
248K-
Virtu Financial LLC New York, NY849KShares$4.69 Million0.43% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA552KShares$3.05 Million0.0% of portfolio
-
Hrt Financial LP New York, NY543KShares$3 Million0.02% of portfolio
-
Chi Advisors LLC New York, NY225KShares$1.24 Million2.28% of portfolio
-
Jane Street Group, LLC New York, NY204KShares$1.12 Million0.0% of portfolio